Publications by authors named "Ian D R Arnott"

Claim this Profile
V
Validation of the ACE [Albumin, CRP, and Endoscopy] Index in Acute Colitis: Analysis of the CONSTRUCT dataset.
Rebecca K Grant, Gareth-Rhys Jones, Nikolas Plevris, Ruairi W Lynch, William M Brindle, Ian D R Arnott

J Crohns Colitis· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Value of a Dedicated IBD Flare Clinic to Effectively Manage Exacerbations of Inflammatory Bowel Disease: The Edinburgh IBD Unit.
Rebecca K Grant, William M Brindle, Ian D R Arnott

Inflamm Bowel Dis· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors associated with unhealed perineal wounds post-proctectomy for perianal Crohn's disease: a two-centre study.
Rebecca K Grant, Alfonso Elosua-González, Sonia Bouri, Kapil Sahnan, William M Brindle, Ian D R Arnott

Colorectal Dis· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19: Colorectal cancer endoscopic surveillance in IBD.
Shahida Din, Daniel R Gaya, Ian D R Arnott

Lancet Gastroenterol Hepatol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of collagenous colitis in NHS Lothian: a population-based study.
Rebecca K Grant, William M Brindle, Andrew J Robertson, Alexander R Robertson, Gareth-Rhys Jones, Ian D R Arnott

Frontline Gastroenterol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ACE (Albumin, CRP and Endoscopy) Index in Acute Colitis: A Simple Clinical Index on Admission that Predicts Outcome in Patients With Acute Ulcerative Colitis.
Rebecca K Grant, Gareth-Rhys Jones, Nikolas Plevris, Ruairi W Lynch, Philip W Jenkinson, Ian D R Arnott

Inflamm Bowel Dis· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility and diagnostic accuracy of faecal calprotectin for IBD at first presentation to gastroenterology services in adults aged 16-50 years.
Nicholas A Kennedy, Annalie Clark, Andrew Walkden, Jeff C W Chang, Federica Fascí-Spurio, Ian D R Arnott

J Crohns Colitis· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crohn's disease.
Rahul Kalla, Nicholas T Ventham, Jack Satsangi, Ian D R Arnott

BMJ· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary outcomes for ulcerative colitis inpatients admitted to pediatric hospitals in the United Kingdom.
Richard K Russell, Aimee Protheroe, Michael Roughton, Nick M Croft, M Stephen Murphy, Ian D R Arnott

Inflamm Bowel Dis· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The organisation and structure of inflammatory bowel disease services for children and young people in the UK in 2010: significant progress but still room for improvement.
Michael P Fitzgerald, Sally G Mitton, Aimee Protheroe, Michael Roughton, Richard Driscoll, Ian D R Arnott

Frontline Gastroenterol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic variation in the familial Mediterranean fever gene (MEFV) and risk for Crohn's disease and ulcerative colitis.
Alexandra-Chloé Villani, Mathieu Lemire, Edouard Louis, Mark S Silverberg, Catherine Collette, Ian D R Arnott

PLoS One· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of germline GLI1 variation implicates hedgehog signalling in the regulation of intestinal inflammatory pathways.
Charlie W Lees, William J Zacharias, Mark Tremelling, Colin L Noble, Elaine R Nimmo, Ian D R Arnott

PLoS Med· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of methotrexate in refractory Crohn's disease: the Edinburgh experience.
Shahida Din, Anna Dahele, Janice Fennel, Sue Aitken, Alan G Shand, Ian D R Arnott

Inflamm Bowel Dis· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does cigarette smoking influence the phenotype of Crohn's disease? Analysis using the Montreal classification.
Marian C Aldhous, Hazel E Drummond, Niall Anderson, Linda A Smith, Ian D R Arnott

Am J Gastroenterol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smoking habit and load influence age at diagnosis and disease extent in ulcerative colitis.
Marian C Aldhous, Hazel E Drummond, Niall Anderson, M Reza Baneshi, Linda A Smith, Ian D R Arnott

Am J Gastroenterol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of infliximab in ulcerative colitis: further questions.
Charles W Lees, Alan G Shand, Ian D Penman, Jack Satsangi, Ian D R Arnott

Inflamm Bowel Dis· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn's disease.
Colin L Noble, Elaine R Nimmo, Hazel Drummond, Gwo-Tzer Ho, Albert Tenesa, Ian D R Arnott

Gastroenterology· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.
Mark S Silverberg, Jack Satsangi, Tariq Ahmad, Ian D R Arnott, Charles N Bernstein

Can J Gastroenterol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype.
Ian D R Arnott, Carol J Landers, Elaine J Nimmo, Hazel E Drummond, Ben K R Smith

Am J Gastroenterol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease location, anti-Saccharomyces cerevisiae antibody, and NOD2/CARD15 genotype influence the progression of disease behavior in Crohn's disease.
Ben R K Smith, Ian D R Arnott, Hazel E Drummond, Elaine R Nimmo, Jack Satsangi

Inflamm Bowel Dis· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical utility of wireless capsule endoscopy.
Ian D R Arnott, Simon K Lo

Dig Dis Sci· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azathioprine and anti-TNF alpha therapies in Crohn's disease: a review of pharmacology, clinical efficacy and safety.
Ian D R Arnott, David Watts, Jack Satsangi

Pharmacol Res· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful infliximab treatment for steroid-refractory celiac disease: a case report.
Helen R Gillett, Ian D R Arnott, Margaret McIntyre, Simon Campbell, Anna Dahele

Gastroenterology· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis